Literature DB >> 20870940

Essential role of complement mannose-binding lectin-associated serine proteases-1/3 in the murine collagen antibody-induced model of inflammatory arthritis.

Nirmal K Banda1, Minoru Takahashi, Brandt Levitt, Magdalena Glogowska, Jessica Nicholas, Kazue Takahashi, Gregory L Stahl, Teizo Fujita, William P Arend, V Michael Holers.   

Abstract

Gene-targeted mice deficient in the complement mannose-binding lectin-associated serine protease-1 and -3 (MASP1/3(-/-)) express only the zymogen of factor D (pro-factor D [pro-Df]), a necessary component of the alternative pathway (AP). We used the murine collagen Ab-induced arthritis (CAIA) model, in which the AP is unique among complement pathways in being both necessary and sufficient for disease induction, to determine whether MASP-1/3 are required in vivo for the development of tissue injury. Disease activity scores, complement C3 tissue deposition in the joint, and histopathologic injury scores were markedly decreased in MASP1/3(-/-) as compared with wild-type (WT) mice. MASP-1 protein was immunochemically localized to synovial cells of knees of WT mice with arthritis. Pro-Df was present in both synovial cells and chondrocytes of knees of WT and MASP1/3(-/-) mice without arthritis, with increased amounts present in synovial cells of WT mice with CAIA. No conversion of pro-Df to mature Df was detectable in the serum of MASP1/3(-/-) mice during the evolution of CAIA. C3 activation and deposition as well as C5a generation induced in vitro by adherent anti-type II collagen mAbs were absent using sera from MASP1/3(-/-) mice under conditions in which only the AP was active. The addition of human Df fully reconstituted in vitro C3 activation and C5a generation using sera from MASP1/3(-/-) mice. Our studies demonstrate for the first time, to our knowledge, the absolute requirement for the activity of MASP-1 protein in autoimmune-associated inflammatory tissue injury in vivo through activation of the AP of complement by cleavage of pro-Df to mature Df.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20870940      PMCID: PMC3157645          DOI: 10.4049/jimmunol.1001564

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

Review 1.  Complement. Second of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-12       Impact factor: 91.245

Review 2.  Complement. First of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

Review 3.  The role of complement in B cell activation and tolerance.

Authors:  M C Carroll
Journal:  Adv Immunol       Date:  2000       Impact factor: 3.543

Review 4.  The biological functions of MBL-associated serine proteases (MASPs).

Authors:  Krishnan Hajela; Mayumi Kojima; Geza Ambrus; K H Nicky Wong; Beryl E Moffatt; Janez Ferluga; Sumati Hajela; Peter Gál; Robert B Sim
Journal:  Immunobiology       Date:  2002-09       Impact factor: 3.144

Review 5.  The lectin-complement pathway--its role in innate immunity and evolution.

Authors:  Teizo Fujita; Misao Matsushita; Yuichi Endo
Journal:  Immunol Rev       Date:  2004-04       Impact factor: 12.988

Review 6.  The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease.

Authors:  Paul A Monach; Christophe Benoist; Diane Mathis
Journal:  Adv Immunol       Date:  2004       Impact factor: 3.543

7.  Complement activation in factor D-deficient mice.

Authors:  Y Xu; M Ma; G C Ippolito; H W Schroeder; M C Carroll; J E Volanakis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

Review 8.  Mannose-binding lectin: structure, function, genetics and disease associations.

Authors:  M W Turner; R M Hamvas
Journal:  Rev Immunogenet       Date:  2000

9.  MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway.

Authors:  M R Dahl; S Thiel; M Matsushita; T Fujita; A C Willis; T Christensen; T Vorup-Jensen; J C Jensenius
Journal:  Immunity       Date:  2001-07       Impact factor: 31.745

10.  Murine serine proteases MASP-1 and MASP-3, components of the lectin pathway activation complex of complement, are encoded by a single structural gene.

Authors:  C M Stover; N J Lynch; M R Dahl; S Hanson; M Takahashi; M Frankenberger; L Ziegler-Heitbrock; I Eperon; S Thiel; W J Schwaeble
Journal:  Genes Immun       Date:  2003-07       Impact factor: 2.676

View more
  25 in total

1.  Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation.

Authors:  Guilherme Baldo; Susan Wu; Ruth A Howe; Meera Ramamoothy; Russell H Knutsen; Jiali Fang; Robert P Mecham; Yuli Liu; Xiaobo Wu; John P Atkinson; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2011-08-24       Impact factor: 4.797

2.  Roles of adipocytes and fibroblasts in activation of the alternative pathway of complement in inflammatory arthritis in mice.

Authors:  William P Arend; Gaurav Mehta; Alexandra H Antonioli; Minoru Takahashi; Kazue Takahashi; Gregory L Stahl; V Michael Holers; Nirmal K Banda
Journal:  J Immunol       Date:  2013-05-06       Impact factor: 5.422

Review 3.  Targeting mechanisms at sites of complement activation for imaging and therapy.

Authors:  V Michael Holers
Journal:  Immunobiology       Date:  2015-04-30       Impact factor: 3.144

4.  Mechanisms of mannose-binding lectin-associated serine proteases-1/3 activation of the alternative pathway of complement.

Authors:  Nirmal K Banda; Minoru Takahashi; Kazue Takahashi; Gregory L Stahl; Stephanie Hyatt; Magdalena Glogowska; Timothy A Wiles; Yuichi Endo; Teizo Fujita; V Michael Holers; William P Arend
Journal:  Mol Immunol       Date:  2011-09-23       Impact factor: 4.407

5.  Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice.

Authors:  Nirmal K Banda; Stephanie Hyatt; Alexandra H Antonioli; Jason T White; Magdalena Glogowska; Kazue Takahashi; Tod J Merkel; Gregory L Stahl; Stacey Mueller-Ortiz; Rick Wetsel; William P Arend; V Michael Holers
Journal:  J Immunol       Date:  2011-12-28       Impact factor: 5.422

Review 6.  Antibody-dependent and -independent mechanisms of inflammatory arthritis.

Authors:  Margaret H Chang; Peter A Nigrovic
Journal:  JCI Insight       Date:  2019-03-07

Review 7.  Mannose-binding lectin and the balance between immune protection and complication.

Authors:  Kazue Takahashi
Journal:  Expert Rev Anti Infect Ther       Date:  2011-12       Impact factor: 5.091

8.  Mannan-Binding Lectin-Associated Serine Protease 1/3 Cleavage of Pro-Factor D into Factor D In Vivo and Attenuation of Collagen Antibody-Induced Arthritis through Their Targeted Inhibition by RNA Interference-Mediated Gene Silencing.

Authors:  Nirmal K Banda; Sumitra Acharya; Robert I Scheinman; Gaurav Mehta; Marilyne Coulombe; Minoru Takahashi; Hideharu Sekine; Steffen Thiel; Teizo Fujita; V Michael Holers
Journal:  J Immunol       Date:  2016-10-05       Impact factor: 5.422

9.  Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis.

Authors:  V C Willis; N K Banda; K N Cordova; P E Chandra; W H Robinson; D C Cooper; D Lugo; G Mehta; S Taylor; P P Tak; R K Prinjha; H D Lewis; V M Holers
Journal:  Clin Exp Immunol       Date:  2017-03-09       Impact factor: 4.330

Review 10.  Novel mechanisms of action of the biologicals in rheumatic diseases.

Authors:  Cecilia Beatrice Chighizola; Ennio Giulio Favalli; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.